Atlas Trials

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Clinical trial NCT01746992 · UNKNOWN

Trial details

NCT number
NCT01746992
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
ALK-negative Anaplastic Large Cell LymphomaPeripherial T Cell Lymphoma,Not Otherwise SpecifiedAngioimmunoblastic T Cell LymphomaEnteropathy Associated T Cell LymphomaHepatosplenic T Cell LymphomaSubcutaneous Panniculitis Like T Cell Lymphoma
Start date
2012-09-01
Primary completion
2018-09-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.